First Time Loading...

Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 37.94 USD 3.32% Market Closed
Updated: May 29, 2024

Biohaven Pharmaceutical Holding Company Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biohaven Pharmaceutical Holding Company Ltd
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Total Liabilities
$85.2m
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$140.9B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$38.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$88B
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.4B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
22%

See Also

What is Biohaven Pharmaceutical Holding Company Ltd's Total Liabilities?
Total Liabilities
85.2m USD

Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Total Liabilities amounts to 85.2m USD.

What is Biohaven Pharmaceutical Holding Company Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
-3%

Over the last year, the Total Liabilities growth was -31%. The average annual Total Liabilities growth rates for Biohaven Pharmaceutical Holding Company Ltd have been -3% over the past three years .